Labshake search
Citations for Tocris :
51 - 100 of 232 citations for Human Rh Blood Group D Antigen RHD CLIA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... D-AP5 (100 μM, Tocris Bioscience ...
-
bioRxiv - Neuroscience 2024Quote: ... D-AP-5 50μM (Tocris) were added to the ASCF.
-
bioRxiv - Neuroscience 2020Quote: ... we utilized another widely used group II mGluR agonist LY379268 (Tocris, product 2453; Monn et al., 1999). Both compounds were prepared in sterile water and pH increased to 8.5 using 1 N NaOH ...
-
bioRxiv - Neuroscience 2023Quote: ... and then half of each viral group was injected with either the DREADD agonist Deschloroclozapine52 (Tocris # 7193) at 1ug/kg in 1% DMSO or vehicle ...
-
bioRxiv - Biochemistry 2020Quote: ... human BDNF (2837, Tocris), PACAP-38 (4031157 ...
-
bioRxiv - Neuroscience 2022Quote: ... human ghrelin (Tocris, 1463), recombinant mouse leptin (Cedarlane Laboratories Ltd ...
-
bioRxiv - Neuroscience 2021Quote: ... 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5, 0106, Tocris Bioscience, UK), and 10 μM of SR95531 (SR ...
-
bioRxiv - Neuroscience 2019Quote: ... D-2-amino-5-phosphonovalerate (“D-AP5”, 50 mM in PBS, Tocris Cat No 0106); Retigabine (100 mM in DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... the group 2/3 mGluR agonist (DCG-IV) and MNI-glutamate for uncaging experiments were purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... animals in the PE+PSB0739 group were subjected to intracerebroventricular injection (i.c.v) with a single dose of PSB0739 ((Tocris, R&D Systems ...
-
bioRxiv - Developmental Biology 2021Quote: ... (S)-(+)-Dimethindenemaleate (D, 1 mM; Tocris, 1425) and Minocycline hydrochloride (M ...
-
bioRxiv - Neuroscience 2021Quote: ... D-amphetamine (in sulfate formulation; Tocris) was used at 4mg/kg (31) ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 μM D-AP5 (Tocris) in the bath solution ...
-
bioRxiv - Physiology 2023Quote: ... For [D-Ala2]-GIP (6699, Tocris), mice were injected with a single dose of [D-Ala2]-GIP (0.1 μg ...
-
Autism genes converge on microtubule biology and RNA-binding proteins during excitatory neurogenesisbioRxiv - Systems Biology 2024Quote: ... 10uM DAPT (D)(Tocris, Cat#2634). Media was refreshed every three days ...
-
bioRxiv - Neuroscience 2024Quote: ... and D-APV (50 μM, Tocris), to selectively block glutamatergic signalling ...
-
bioRxiv - Developmental Biology 2024Quote: ... 2.5 µM Y27632 (R&D/Tocris), 25 ng/mL rhEGF (R&D/Tocris) ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [D-Pen2,D-Pen5]Enkephalin (DPDPE) and racemic U-50,488 HCl were purchased from Tocris (Minneapolis, MN). Naltrexone hydrochloride was purchased from Sigma Aldrich (St ...
-
bioRxiv - Neuroscience 2019Quote: ... a final group of animals (n=4) received a DBB infusion of K-234 (1 nmol/0.5 µl/per side; Tocris Bioscience ...
-
bioRxiv - Neuroscience 2022Quote: ... CFA and paw incision groups of mice received daily intraperitoneal (i.p.) injections of saline (vehicle) or YM155 (Tocris Biosciences), an Interleukin Enhancer Binding Factor 3 (ILF3 ...
-
bioRxiv - Neuroscience 2020Quote: ... D-APV (50 μM; Tocris, Cat# 0106) synthetic Aβ1-42 (1.5 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... d-amphetamine sulphate (2 mg/kg, Tocris), JZL184 (8 mg/kg ...
-
bioRxiv - Neuroscience 2021Quote: ... D-AP5 (Tocris Bioscience, 0106, 30 mM), an N-methyl-D-aspartate receptor blocker ...
-
bioRxiv - Neuroscience 2020Quote: ... D-AP5 (50 μM, NMDAR antagonist, Tocris), CGP 55845 were added into ACSF solution ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 D-APV (all from Tocris).
-
bioRxiv - Neuroscience 2020Quote: ... 100 μM D-APV (Tocris, Cat #0106) was added to the extracellular solution of both barrels to prevent the contribution of NMDA receptor currents ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50 μM D-AP5 (Tocris #3693) for 2 minutes in conditioned medium ...
-
bioRxiv - Neuroscience 2021Quote: ... D-Glucose and NaCl) plus dorsomorphin (Tocris) every day over 2-3 weeks ...
-
bioRxiv - Immunology 2022Quote: ... Cytochalsin D (1233) was purchased from Tocris.
-
bioRxiv - Neuroscience 2022Quote: ... 50 μM D-APV (Tocris Cat#0106) was included in ACSF ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.1mM D-luciferin sodium salt (Tocris). 1µM VIP (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... N-Methyl-D-Aspartate (NMDA, Tocris®). 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt ...
-
bioRxiv - Cell Biology 2023Quote: ... and 100 μM D-AP5 (Tocris Biosciences), and a subset was also treated with 50 μM Thiamet-G ...
-
Astrocytic Neuroligins Are Not Required for Synapse Formation or a Normal Astrocyte CytoarchitecturebioRxiv - Neuroscience 2023Quote: ... 50 μM D-AP5 (Tocris, Cat. 0106), and 0.5 μM TTX ...
-
bioRxiv - Developmental Biology 2024Quote: ... 25 ng/mL rhEGF (R&D/Tocris), 0.8 mM Valproic Acid (Amsbio) ...
-
bioRxiv - Neuroscience 2021Quote: ... an agonist of group II metabotropic glutamate receptors (mGluR2/3) that reduces release probability in mossy fiber terminals (1 μM, Tocris)(Kamiya et al. ...
-
bioRxiv - Microbiology 2023Quote: ... the lepirudin-treated blood was immediately divided and sterile compstatin (Tocris #2585), or an equivalent volume of sterile PBS vehicle ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 20 μM D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) (Tocris Bioscience) to block glycine- ...
-
bioRxiv - Immunology 2023Quote: ... the human Aβ42 peptide (Tocris Bioscience) was dissolved at a concentration of 100 nM in 50 μ𝓁 of 0.1 M sodium bicarbonate coating buffer (pH 8.6) ...
-
bioRxiv - Genomics 2021Quote: ... neurons were made quiescent for 2 hours with 100 μM D-2- amino-5-phosphonopentanoic acid (D-AP5; Tocris #0106) and 1 μM tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2020Quote: ... QX-314 (Cat No. 1014); and D-2-amino-5-phosphonovalerate (D-AP5; Cat No. 0106) were purchased from Tocris.
-
bioRxiv - Neuroscience 2020Quote: ... During BQA experiments the ACSF solution contained the following substances: 10 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... and a fourth group (DZP) received 2 mg/kg diazepam (CAS #439-14-5; Tocris, 2805; German-Ponciano et al., 2020) as a pharmacological control of anxiolytic activity ...
-
bioRxiv - Neuroscience 2021Quote: ... and 0.1 mM D-Luciferin sodium salt (Tocris). The SCN slice position was adjusted to the center of the dish and 1.5μl AAV (pAAV1-Syn-ChrimsonR-tdT ...
-
bioRxiv - Cell Biology 2022Quote: ... we used cytochalasin D at 0.5 μM (TOCRIS) for 30 min ...
-
bioRxiv - Neuroscience 2021Quote: ... D-AP5 (50 µM, Tocris, Cat. No. 0106), 4-AP (200 µM ...
-
Presynaptic mitochondria volume and abundance increase during development of a high-fidelity synapsebioRxiv - Neuroscience 2019Quote: ... 50 μM D-AP-5 (Tocris, Cat# 0106) to block NMDA receptors ...
-
bioRxiv - Neuroscience 2020Quote: ... NMDA receptor blockers (D-AP5 50 μM, Tocris; (+)MK-801 10 μM ...
-
bioRxiv - Neuroscience 2021Quote: ... D-APV and DCGIV were purchased from Tocris Bioscience ...